BCL2L11 and B-cell non-Hodgkin lymphoma: This result suggests that in addition to EBNA3C, other viral and/or cellular factors can suppress BIM expression in EBV-induced B-cell lymphomas with type III latency in the cord blood-humanized mouse model.